Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Pharmagreen Biotech Inc. | ex311.htm |
| 10-Q - PBI FORM 10-Q - Pharmagreen Biotech Inc. | 10qpbi.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Pharmagreen Biotech Inc. (the “Company”) for the quarter ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the Report), we, Peter Wojcik, Principal Executive Officer of the Company and Terry Kwan, Principal Financial Officer of the Company certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.
May 24, 2021 | |
|
|
/s/ Peter Wojcik |
|
Peter Wojcik |
|
President and Director Principal Executive Officer
|
|
|
|
/s/ Terry Kwan |
|
Terry Kwan Principal Accounting Officer |
|
1